Are you or a family member with LGMD2A interested in participating in clinical research studies or trials? Click here to view C3’s new Clinical Research Opportunity Resource Center to learn more about clinical research and current opportunities to participate. This
University of Florida College of Medicine Study Recruiting LGMD2A Patients Living in the Southeast U.S. and Texas
Individuals with LGMD2A, a form of calpainopathy, are being sought for a Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS) study. Please direct any questions related to this study, including participation guidelines and aims, to Dr. Glenn Walter, University of Florida
Published Research Alert: Gene Correction of LGMD2A Specific iPSCs for the Development of Targeted Autologous Cell Therapy
Coalition to Cure Calpain 3 (C3) is pleased to announce the publication of important research undertaken by Dr. Rita Perlingeiro, Professor of Medicine, University of Minnesota, and colleagues. The paper, titled “Gene Correction of LGMD2A Specific iPSCs for the Development of Targeted Autologous
Together we are STRONGER: 5th Annual LGMD Awareness Day is Coming Up!
The 5th annual Limb Girdle Muscular Dystrophy Awareness Day is coming up on September 30, 2019. Help C3 raise awareness of LGMD in your community and through social media. It’s time to: 1. Start planning to wear Lime Green on
Individuals with LGMD are sought for clinical trial evaluating the safety and efficacy of oral weekly glucocorticoid steroids
A clinical trial is being initiated at Northwestern University in Chicago, Illinois. The aim of the study is to test the safety and efficacy of once weekly dosing of oral prednisone, a glucocorticoid steroid. Both ambulatory and nonambulatory patients
English
አማርኛ
العربية
简体中文
繁體中文
Dansk
Nederlands
Français
Deutsch
עִבְרִית
हिन्दी
Italiano
日本語
ភាសាខ្មែរ
한국어
كوردی
मराठी
Norsk bokmål
Polski
Português
ਪੰਜਾਬੀ
Русский
Español
Svenska
தமிழ்
తెలుగు
Türkçe